In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease

References

• MeadPSEpidemiology of Lyme diseaseInfect Dis Clin North Am201529218721025999219
   PubMed Web of Science ®Google Scholar
• LogiudiceKOstfeldRSSchmidtKAKeesingFThe ecology of infectious disease: effects of host diversity and community composition on Lyme disease riskProc Natl Acad Sci U S A2003100256757112525705
   PubMed Web of Science ®Google Scholar
• SalkeldDJNietoNCCarbajales-DalePCarbajales-DaleMCinkovichSSLambinEFDisease risk & landscape attributes of tick-borne Borrelia pathogens in the San Francisco Bay Area, CaliforniaPLoS One2015108e013481226288371
   PubMed Web of Science ®Google Scholar
• Aguero-RosenfeldMEWormserGPLyme disease: diagnostic issues and controversiesExpert Rev Mol Diagn20151511425482091
   PubMed Web of Science ®Google Scholar
• SmithAJOertleJPratoDChronic Lyme disease: persistent clinical symptoms related to immune evasion, antibiotic resistance and various defense mechanisms of Borrelia burgdorferiOpen J Med Microbiol201444252260
   Google Scholar
• MarquesAChronic Lyme disease: a reviewInfect Dis Clin North Am200822234136018452806
   PubMed Web of Science ®Google Scholar
• BockenstedtLKRadolfJDXenodiagnosis for posttreatment Lyme disease syndrome: resolving the conundrum or adding to it?Clin Infect Dis201458794694824523213
   PubMed Web of Science ®Google Scholar
• BockenstedtLKGonzalezDGHabermanAMBelperronAASpirochete antigens persist near cartilage after murine Lyme borreliosis therapyJ Clin Invest201212272652266022728937
   PubMed Web of Science ®Google Scholar
• HodzicEFengSHoldenKFreetKJBartholdSWPersistence of Borrelia burgdorferi following antibiotic treatment in miceAntimicrob Agents Chemother20085251728173618316520
   PubMed Web of Science ®Google Scholar
• WormserGPDattwylerRJShapiroEDThe clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of AmericaClin Infect Dis20064391089113417029130
   PubMed Web of Science ®Google Scholar
• HunfeldKPRuzic-SabljicENorrisDEKraiczyPStrleFIn vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapyAntimicrob Agents Chemother20054941294130115793100
   PubMed Web of Science ®Google Scholar
• MiklossyJKasasSZurnADMccallSYuSMcgeerPLPersisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosisJ Neuroinflammation200854018817547
   PubMed Web of Science ®Google Scholar
• SharmaBBrownAVMatluckNEHuLTLewisKBorrelia burgdorferi, the causative agent of Lyme disease, forms drug-tolerant persister cellsAntimicrob Agents Chemother20155984616462426014929
   PubMed Web of Science ®Google Scholar
• FengJAuwaerterPGZhangYDrug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycyclinePLoS One2015103e011720725806811
   PubMed Web of Science ®Google Scholar
• HunfeldKPRödelRWichelhausTAIn vitro activity of eight oral cephalosporins against Borrelia burgdorferiInt J Antimicrob Agents200321431331812672576
   PubMed Web of Science ®Google Scholar
• AggerWACallisterSMJobeDAIn vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxoneAntimicrob Agents Chemother1992368178817901416868
   PubMed Web of Science ®Google Scholar
• FontanaRCornagliaGLigozziMMazzariolAThe final goal: penicillin-binding proteins and the target of cephalosporinsClin Microbiol Infect20006Suppl 33440
   PubMed Web of Science ®Google Scholar
• TrottOOlsonAJAutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJ Comput Chem201031245546119499576
   PubMed Web of Science ®Google Scholar
• WeigelLMBelisleJTRadolfJDNorgardMVDigoxigenin-ampicillin conjugate for detection of penicillin-binding proteins by chemiluminescenceAntimicrob Agents Chemother19943823303368192459
   PubMed Web of Science ®Google Scholar
• NorgardMVBakerSIRadolfJDChemiluminescent analysis of Borrelia burgdorferi penicillin-binding proteins using ampicillin conjugated to digoxigeninMicrob Pathog19951942572728825913
   PubMed Web of Science ®Google Scholar
• WaghDPothineniVRInayathullahMLiuSKimKMRajadasJBorreliacidal activity of Borrelia metal transporter A (BmtA) binding small molecules by manganese transport inhibitionDrug Des Devel Ther20159805
   PubMed Web of Science ®Google Scholar
• SapiEKaurNAnyanwuSEvaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferiInfect Drug Resist201149711321753890
   PubMedGoogle Scholar
• PothineniVRWaghDBabarMMIdentification of new drug candidates against Borrelia burgdorferi using high-throughput screeningDrug Des Devel Ther20161013071322
   PubMed Web of Science ®Google Scholar
• PaviaCSWormserGPNowakowskiJCacciapuotiAEfficacy of an evernimicin (SCH27899) in vitro and in an animal model of Lyme diseaseAntimicrob Agents Chemother200145393693711181384
   PubMed Web of Science ®Google Scholar
• AshrafZRafiqMSeoSYKwonKSBabarMMZaidiNUKinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinaseEur J Med Chem20159820321126025140
   PubMed Web of Science ®Google Scholar
• StudioDversion 2.5San Diego, CA, USAAccelrys Inc2009
   Google Scholar
• Kosowska-ShickKMcgheePLAppelbaumPCAffinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniaeAntimicrob Agents Chemother20105451670167720194704
   PubMed Web of Science ®Google Scholar
• PothineniVRWaghDBabarMMScreening of NCI-DTP library to identify new drug candidates for Borrelia burgdorferiJ Antibiot201770330831227826144
   PubMed Web of Science ®Google Scholar
• VeinovićGCerarTStrleFIn vitro susceptibility of European human Borrelia burgdorferi sensu stricto strains to antimicrobial agentsInt J Antimicrob Agents201341328829123312603
   PubMed Web of Science ®Google Scholar
• StapleyEOBirnbaumJMillerAKWallickHHendlinDWoodruffHBCefoxitin and cephamycins: microbiological studiesRev Infect Dis1979117387400941
   PubMedGoogle Scholar
• SandersCVGreenbergRNMarierRLCefamandole and cefoxitinAnn Intern Med1985103170783890658
   PubMed Web of Science ®Google Scholar
• JohnsonRCKodnerCBJurkovichPJCollinsJJComparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agentsAntimicrob Agents Chemother19903411213321362073103
   PubMed Web of Science ®Google Scholar
• UrbanCRahalJJDattwyllerRJGorevicPLuftBJPenicillin-binding proteins in Borrelia burgdorferiJ Bacteriol199017210613961412211530
   PubMed Web of Science ®Google Scholar